Latest market price
265.56
+1.38+0.52%
TA
Loading chart...
Snapshot
| Index | S&P 500 | P/E | 49.27 | EPS (ttm) | 5.39 | Insider Own | 1.12% | Shs Outstand | 64.27M | Perf Week | -3.54% |
| Market Cap | 17.07B | Forward P/E | 41.93 | EPS next Y | 6.33 | Insider Trans | -0.08% | Shs Float | 63.62M | Perf Month | -1.15% |
| Enterprise Value | 23.63B | PEG | — | EPS next Q | 1.49 | Short Float | 3.96% | Perf Quarter | -7.54% | ||
| Income | 349.00M | P/S | 8.77 | EPS this Y | -47.03% | Short Ratio | 5.14 | Perf Half Y | 0.34% | ||
| Sales | 1.95B | P/B | 3.13 | EPS next Y | 13.73% | ROA | 2.73% | Short Interest | 2.52M | Perf YTD | 1.48% |
| Book/sh | 84.94 | P/C | — | EPS next 5Y | — | ROE | 6.48% | 52W High | 303.35 -12.46% | Perf Year | 6.30% |
| Cash/sh | 1.24 | P/FCF | 17.38 | EPS past 3/5Y | 18.41% 3.70% | ROIC | 263.88% | 52W Low | 238.46 11.36% | Perf 3Y | 27.34% |
| Dividend Est. | 10.36 (3.90%) | EV/EBITDA | 19.10 | Sales past 3/5Y | 5.76% 4.91% | Gross Margin | 68.69% | Volatility | 2.05% 1.93% | Perf 5Y | -20.70% |
| Dividend TTM | 10.34 (3.89%) | EV/Sales | 12.13 | EPS Y/Y TTM | -59.07% | Oper. Margin | 29.04% | ATR (14) | 5.75 | Perf 10Y | 28.49% |
| Dividend Ex-Date | Sep 30, 2026 | Quick Ratio | 3.97 | Sales Y/Y TTM | 3.84% | Profit Margin | 17.99% | RSI (14) | 42.85 | Recom | 2.70 |
| Dividend Gr. 3/5Y | 4.91% 4.10% | Current Ratio | 3.97 | EPS Q/Q | -40.62% | SMA20 | -1.86% | Beta | 0.69 | Target Price | 300.73 |
| Payout | 189.72% | Debt/Eq | 1.22 | Sales Q/Q | 4.23% | SMA50 | -3.05% | Rel Volume | 1.43 | Prev Close | 264.18 |
| Employees | 1,688 | LT Debt/Eq | 1.21 | Earnings | Feb 03 | SMA200 | -1.58% | Avg Volume | 512.50K | Price | 265.56 |
| IPO Date | Jun 07, 1994 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 3.06% 0.34% | Net Debt/EBITDA | 5.30 | Volume | 732,313 | Change | 0.52% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-29-26 | Reiterated | Piper Sandler | Overweight | $326 → $320 |
| Oct-28-26 | Reiterated | Stifel Nicolaus | Buy | $293 → $286 |
| Oct-14-26 | Reiterated | Barclays | Equal Weight | $296 → $285 |
| Oct-12-26 | Reiterated | Piper Sandler | Overweight | $352 → $326 |
| Sep-21-26 | Reiterated | Evercore ISI Group | Outperform | $303 → $299 |
| Sep-17-26 | Reiterated | Scotiabank | Sector Outperform | $307 → $293 |
| Sep-15-26 | Reiterated | UBS | Neutral | $278 → $286 |
| Sep-08-26 | Downgrade | Mizuho | Outperform → Neutral | $308 → $295 |
| Aug-18-26 | Reiterated | Deutsche Bank | Buy | $330 → $325 |
| Aug-03-26 | Reiterated | Cantor Fitzgerald | Overweight | $330 → $316 |
Latest News· Times ET
Oct-30-26
Oct-30-2607:17AM
Oct-29-26
Oct-28-26
06:06PM
Oct-27-26
Oct-27-2609:31PM
07:21PM
04:19PM
Oct-26-26
Oct-22-26
09:00AM
Oct-20-26
Oct-18-26
Oct-14-26
Oct-11-26
Company
Essex Property Trust, Inc., a prominent S&P 500 constituent, operates as a vertically integrated real estate investment trust (REIT). The company focuses on the purchase, construction, renovation, and ongoing management of residential apartment complexes across select West Coast regions.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,947 | 1,901 | 1,774 | 1,669 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 609 | 593 | 567 | 532 | — | — | — | — | — | |
| Gross Profit | 1,338 | 1,308 | 1,208 | 1,137 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 127 | 69 | 99 | 63 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 644 | 405 | 406 | 490 | — | — | — | — | — | |
| Operating Income | 566 | 834 | 703 | 584 | — | — | — | — | — | |
| Interest Expense | 259 | 257 | 236 | 213 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 57 | 121 | 344 | 59 | — | — | — | — | — | |
| Net Income Before Taxes | 363 | 698 | 811 | 431 | — | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Consolidated Net Income | 349 | 672 | 742 | 406 | — | — | — | — | — | |
| Net Income From Continuing Operations | 364 | 698 | 811 | 431 | — | — | — | — | — | |
| Net Income | 349 | 672 | 742 | 406 | — | — | — | — | — | |
| EPS (Recurring) | 5.40 | 10.41 | 11.55 | 6.32 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 5.40 | 10.41 | 11.55 | 6.32 | — | — | — | — | — | |
| EPS (Diluted) | 5.39 | 10.41 | 11.54 | 6.32 | — | — | — | — | — | |
| EBITDA | 1,237 | 1,563 | 1,627 | 1,192 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 49.27 | 25.14 | 24.73 | 39.23 | — | — | — | — | — | |
| Price To Sales Ratio | 8.73 | 8.81 | 10.30 | 9.51 | — | — | — | — | — | |
| Gross Margin | 68.72 | 68.81 | 68.09 | 68.12 | — | — | — | — | — | |
| Operating Margin | 29.07 | 43.87 | 39.63 | 34.99 | — | — | — | — | — | |
| Net Margin | 17.93 | 35.35 | 41.83 | 24.33 | — | — | — | — | — | |
| Shares Outstanding | 64 | 64 | 64 | 64 | — | — | — | — | — | |
| Market Capitalization | 16,996 | 16,748 | 18,268 | 15,868 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Kasaris Mary | Director | May 27 '26 | Sale | 279.45 | 600 | 167,670 | 2,394 | May 29 |
| MARCUS GEORGE M | Director | May 28 '25 | Option Exercise | 216.31 | 13,418 | 2,902,448 | 221,925 | May 30 |
| Kasaris Mary | Director | Mar 11 '25 | Option Exercise | 216.31 | 2,800 | 605,668 | 4,555 | Mar 13 |
| Kasaris Mary | Director | Mar 11 '25 | Sale | 300.80 | 2,800 | 842,240 | 1,755 | Mar 13 |
| Kleiman Angela L. | President and CEO | Mar 04 '25 | Sale | 315.12 | 400 | 126,048 | 13,662 | Mar 05 |
| Kleiman Angela L. | President and CEO | Mar 04 '25 | Option Exercise | 214.79 | 400 | 85,916 | 14,062 | Mar 05 |
| Pak Barbara | Executive Vice President & CFO | Mar 03 '25 | Option Exercise | 214.79 | 6,318 | 1,357,043 | 14,972 | Mar 05 |
| Kleiman Angela L. | President and CEO | Mar 03 '25 | Option Exercise | 214.79 | 4,929 | 1,058,700 | 18,591 | Mar 05 |
| Kleiman Angela L. | President and CEO | Mar 03 '25 | Sale | 314.99 | 4,929 | 1,552,586 | 13,662 | Mar 05 |
| GUERICKE KEITH R | Director | Mar 03 '25 | Option Exercise | 216.31 | 7,298 | 1,578,630 | 23,416 | Mar 05 |
| GUERICKE KEITH R | Director | Mar 03 '25 | Sale | 315.00 | 7,298 | 2,298,870 | 16,118 | Mar 05 |
| Morrison Anne | EVP, CAO & General Counsel | Mar 03 '25 | Option Exercise | 214.79 | 2,571 | 552,225 | 5,960 | Mar 05 |
| Morrison Anne | EVP, CAO & General Counsel | Mar 03 '25 | Sale | 314.79 | 2,571 | 809,325 | 3,389 | Mar 05 |
| Pak Barbara | Executive Vice President & CFO | Mar 03 '25 | Sale | 314.79 | 6,318 | 1,988,843 | 8,654 | Mar 05 |
| Johnson Amal M | Director | Sep 17 '24 | Option Exercise | 216.31 | 7,298 | 1,578,630 | 9,883 | Sep 19 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.